Prevalence and Predictors of Unplanned Readmission After Outpatient Breast Cancer Surgery: A Retrospective Cohort Study of 191,559 Patients
This retrospective cohort study of 191,559 patients reveals that while unplanned 30-day readmission rates for outpatient breast cancer surgery have declined despite increased volume, the risk is primarily driven by patient comorbidities like functional dependence and heart failure rather than cancer-specific factors, leading to the development of a validated nomogram for individualized risk stratification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer remains one of the most common health challenges women face worldwide, and surgery has long been the cornerstone of treatment. In recent decades, a significant shift has occurred in how these operations are managed. Instead of staying in the hospital for several days after the procedure, many patients now undergo surgery and return home on the same day. This approach, known as outpatient surgery, relies on advances in pain management and anesthesia to keep patients comfortable without an overnight stay. The goal is to reduce costs and increase patient satisfaction, but it also raises a critical question: is it safe? The primary concern for doctors is the risk of unplanned readmission, where a patient must return to the hospital shortly after discharge because of complications. While sending patients home quickly is generally seen as a positive step, the medical community needed to understand exactly who is safe to send home and who might need to stay in the hospital for observation.
To answer this, researchers conducted a massive review of medical records involving 191,559 women who underwent outpatient breast cancer surgery between 2011 and 2023. They analyzed data from nearly 700 hospitals across the United States to track what happened to these patients within 30 days of their operation. The study focused on identifying which factors made a patient more likely to be readmitted unexpectedly. The results showed that while the overall rate of return to the hospital was low, standing at just 1.82 percent, the risk was not the same for everyone. The likelihood of needing to come back depended heavily on the type of surgery performed and the patient's overall health before the operation.
The researchers found that the extent of the surgery mattered significantly. Women who had a partial mastectomy, where only part of the breast is removed, had the lowest readmission rate at 1.36 percent. Those who had a total mastectomy, involving the removal of the entire breast, saw that rate rise to 2.83 percent. The highest risk group was women undergoing a radical mastectomy, which involves removing the breast and surrounding tissue, with a readmission rate of 3.34 percent. Despite the number of outpatient surgeries increasing seven-fold over the study period, the rate of unplanned returns actually dropped, falling from 2.8 percent in 2011 to 1.6 percent in recent years. This suggests that as hospitals and surgeons gained more experience with these procedures, they became better at selecting the right patients and managing their care.
When the team looked closely at the patients themselves, they discovered that the strongest predictors of a return to the hospital were not related to the cancer itself, but to the patient's general physical condition. The most significant factors included functional dependence, meaning the patient needed help with daily activities like bathing or dressing, and a history of congestive heart failure. Other major risk factors included the need for dialysis, bleeding disorders, and a longer surgery time exceeding two hours. Even the overall health rating given by anesthesiologists before surgery played a role; patients with higher risk ratings were more likely to be readmitted. Interestingly, the study found that complex machine learning algorithms did not predict these outcomes better than a standard statistical model, reinforcing that simple, clear clinical factors are often the most reliable guides.
The study also revealed that the impact of certain health conditions could change depending on the type of surgery. For instance, the use of chronic steroids had a different effect on readmission risk depending on whether the patient had a partial, total, or radical mastectomy. This finding suggests that a single, one-size-fits-all rule for deciding who can go home the same day is not sufficient. Instead, the researchers developed a practical tool, a visual chart called a nomogram, that allows doctors to estimate an individual patient's risk by weighing these specific factors together. This tool helps surgeons make more informed decisions, ensuring that patients with high-risk profiles, such as those with heart failure or significant frailty, receive the appropriate level of care, whether that means an overnight stay or enhanced monitoring after going home.
Ultimately, the research confirms that outpatient breast cancer surgery is safe for the vast majority of patients, but it is not without risk. The safety of the procedure relies heavily on careful selection, particularly for those with significant heart conditions or limited physical independence. The decline in readmission rates over the last decade offers hope that with continued refinement of patient selection and post-operative support, the benefits of same-day discharge can be enjoyed by more women without compromising their safety. The key takeaway is that while the surgery itself has become more efficient, the patient's underlying health remains the most critical factor in determining a smooth recovery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.